{"id":911096,"date":"2025-11-17T23:03:03","date_gmt":"2025-11-18T04:03:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/"},"modified":"2025-11-17T23:03:03","modified_gmt":"2025-11-18T04:03:03","slug":"apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/","title":{"rendered":"Apollomics Announces Changes to its Board of Directors and Composition of Committees"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">FOSTER CITY, Calif., Nov.  17, 2025  (GLOBE NEWSWIRE) &#8212; Apollomics Inc. (Nasdaq: APLM) (\u201cApollomics\u201d or the \u201cCompany\u201d), a California-based late-stage clinical biopharmaceutical company, today announced the following update regarding changes to the Company\u2019s board of directors (\u201cBoard\u201d) and composition of committees.<\/p>\n<p align=\"justify\">On November 16, 2025, Mr. Po-Jen Hsueh resigned from the Board. Mr. Hsueh\u2019s resignation was not related to any disagreement with the Company.<\/p>\n<p align=\"justify\">Pursuant to a meeting of the Board on November 16, 2025, Dr. Ya-Chi (Claudia) Huang was appointed to the Board to fill the vacancy resulting from Mr. Hsueh\u2019s resignation. Dr. Ya-Chi (Claudia) Huang will also replace Mr. Po-Jen Hsueh as a member of the Company\u2019s Audit Committee and Nominating and Corporate Governance Committee. Following these changes and the previously announced appointments of directors, the Company\u2019s Board is comprised of the following seven members: Hung-Wen (Howard) Chen (Chairman), Hong-Jung (Moses) Chen, Yi-Kuei Chen, Hsien-Shu Tsai, Yi-An Chu, Chen-Huan Jan, and Ya-Chi (Claudia) Huang. Moses Chen, Hsien-Shu Tsai, Yi-An Chu, Chen-Huan Jan, and Ya-Chi (Claudia) Huang are independent directors.<\/p>\n<p>\n        <strong>Biographical Information of the New Director<\/strong>\n      <\/p>\n<p>Dr. Ya-Chi (Claudia) Huang brings to the Board extensive experience in biotechnology investment, corporate governance, and research and development across Taiwan&#8217;s biopharmaceutical industry.<\/p>\n<p>Dr. Huang currently serves as Assistant Vice President at Maxpro Ventures, where she leads domestic and international investment activities. Since joining in 2024, she has successfully completed investments in multiple companies and manages their post-investment operations. She also serves as a director of AngenMed Therapeutics.<\/p>\n<p>Previously, Dr. Huang served as Investment Manager at Diamond Biofund (6901.TW), where she independently completed multiple investments and oversaw post-investment management for all of Diamond&#8217;s portfolio companies. She participated in Diamond Biofund&#8217;s IPO on the Taiwan Stock Exchange in 2023. Earlier in her career, she was Deputy Manager in the Research Department at Fubon Securities Investment Services, where she evaluated over 150 unlisted biotech companies in Taiwan, China, and Hong Kong, and contributed to a significant increase in Fubon Securities&#8217; investment banking profits.<\/p>\n<p>Dr. Huang&#8217;s scientific background includes research positions at the National Health Research Institutes, Development Center for Biotechnology, and Academia Sinica. Her doctoral research on Epstein-Barr virus was published in Blood and received the Distinguished Thesis Prize in the 12th TienTe Lee Biomedical Award.<\/p>\n<p>Dr. Huang holds a Ph.D. in Microbiology from National Taiwan University College of Medicine and an M.S. in Biological Sciences from National Sun Yat-sen University.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Apollomics Inc.<\/strong><br \/>\n        <br \/>Apollomics Inc.\u00a0is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. Apollomics\u2019 lead program is vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, which is currently in a Phase 2 multicohort clinical trial in\u00a0the United States\u00a0and other countries. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bZraIrBhQ_RgEF1Ews3dpcV1zOdurdqoRtf6SaW1o2woKNDe2Fz84tSDOZGBZ8TZ4nKkpdJGlApKXFDEW_Pg7XaqlhPXkc2wMQ1zNisLH7I=\" rel=\"nofollow\" target=\"_blank\">www.apollomicsinc.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Cautionary Statement Regarding Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release includes statements that constitute \u201cforward-looking statements\u201d within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended (the \u201cSecurities Act\u201d), and Section 21E of the Securities Exchange Act of 1934, as amended (the \u201cExchange Act\u201d). All statements, other than statements of present or historical fact included in this press release, regarding Apollomics\u2019 strategy, prospects, plans, objectives and anticipated outcomes from the development and commercialization of vebreltinib are forward-looking statements. When used in this press release, the words \u201ccould,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cmay,\u201d \u201cbelieve,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cseek,\u201d \u201cproject,\u201d the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management\u2019s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. In addition, Apollomics cautions you that the forward-looking statements contained in this press release are subject to unknown risks, uncertainties and other factors, including those risks and uncertainties discussed in the Annual Report on Form 20-F for the year ended December 31, 2024, filed by Apollomics Inc. with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) under the heading \u201cRisk Factors\u201d and the other documents filed, or to be filed, by Apollomics with the SEC. Additional information concerning these and other factors that may impact the operations and projections discussed herein can be found in the reports that Apollomics has filed and will file from time to time with the SEC. Forward-looking statements speak only as of the date made by Apollomics. Apollomics undertakes no obligation to update publicly any of its forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable law.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NDJjZGVmMzEtZGVkMC00OWVjLTk0NWEtYjQxOGRiMTE2OTIwLTExMzQzMzEtMjAyNS0xMS0xOC1lbg==\/tiny\/Apollomics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Investor Contacts:\r\n\r\nApollomics:\r\nPeter Lin, Chief Financial Officer\r\nApollomics, Inc.\r\nPhone: 1-650-209-4055\r\nEmail: peter.lin@apollomicsinc.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) &#8212; Apollomics Inc. (Nasdaq: APLM) (\u201cApollomics\u201d or the \u201cCompany\u201d), a California-based late-stage clinical biopharmaceutical company, today announced the following update regarding changes to the Company\u2019s board of directors (\u201cBoard\u201d) and composition of committees. On November 16, 2025, Mr. Po-Jen Hsueh resigned from the Board. Mr. Hsueh\u2019s resignation was not related to any disagreement with the Company. Pursuant to a meeting of the Board on November 16, 2025, Dr. Ya-Chi (Claudia) Huang was appointed to the Board to fill the vacancy resulting from Mr. Hsueh\u2019s resignation. Dr. Ya-Chi (Claudia) Huang will also replace Mr. Po-Jen Hsueh as a member of the Company\u2019s Audit Committee and Nominating and Corporate Governance Committee. Following these changes &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Apollomics Announces Changes to its Board of Directors and Composition of Committees&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-911096","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Apollomics Announces Changes to its Board of Directors and Composition of Committees - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apollomics Announces Changes to its Board of Directors and Composition of Committees - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) &#8212; Apollomics Inc. (Nasdaq: APLM) (\u201cApollomics\u201d or the \u201cCompany\u201d), a California-based late-stage clinical biopharmaceutical company, today announced the following update regarding changes to the Company\u2019s board of directors (\u201cBoard\u201d) and composition of committees. On November 16, 2025, Mr. Po-Jen Hsueh resigned from the Board. Mr. Hsueh\u2019s resignation was not related to any disagreement with the Company. Pursuant to a meeting of the Board on November 16, 2025, Dr. Ya-Chi (Claudia) Huang was appointed to the Board to fill the vacancy resulting from Mr. Hsueh\u2019s resignation. Dr. Ya-Chi (Claudia) Huang will also replace Mr. Po-Jen Hsueh as a member of the Company\u2019s Audit Committee and Nominating and Corporate Governance Committee. Following these changes &hellip; Continue reading &quot;Apollomics Announces Changes to its Board of Directors and Composition of Committees&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-18T04:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Apollomics Announces Changes to its Board of Directors and Composition of Committees\",\"datePublished\":\"2025-11-18T04:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/\"},\"wordCount\":816,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/\",\"name\":\"Apollomics Announces Changes to its Board of Directors and Composition of Committees - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=\",\"datePublished\":\"2025-11-18T04:03:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apollomics Announces Changes to its Board of Directors and Composition of Committees\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apollomics Announces Changes to its Board of Directors and Composition of Committees - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/","og_locale":"en_US","og_type":"article","og_title":"Apollomics Announces Changes to its Board of Directors and Composition of Committees - Market Newsdesk","og_description":"FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) &#8212; Apollomics Inc. (Nasdaq: APLM) (\u201cApollomics\u201d or the \u201cCompany\u201d), a California-based late-stage clinical biopharmaceutical company, today announced the following update regarding changes to the Company\u2019s board of directors (\u201cBoard\u201d) and composition of committees. On November 16, 2025, Mr. Po-Jen Hsueh resigned from the Board. Mr. Hsueh\u2019s resignation was not related to any disagreement with the Company. Pursuant to a meeting of the Board on November 16, 2025, Dr. Ya-Chi (Claudia) Huang was appointed to the Board to fill the vacancy resulting from Mr. Hsueh\u2019s resignation. Dr. Ya-Chi (Claudia) Huang will also replace Mr. Po-Jen Hsueh as a member of the Company\u2019s Audit Committee and Nominating and Corporate Governance Committee. Following these changes &hellip; Continue reading \"Apollomics Announces Changes to its Board of Directors and Composition of Committees\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-18T04:03:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Apollomics Announces Changes to its Board of Directors and Composition of Committees","datePublished":"2025-11-18T04:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/"},"wordCount":816,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/","name":"Apollomics Announces Changes to its Board of Directors and Composition of Committees - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=","datePublished":"2025-11-18T04:03:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NzY2NSM3MjY5NzU0IzIxMjI3NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apollomics-announces-changes-to-its-board-of-directors-and-composition-of-committees\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Apollomics Announces Changes to its Board of Directors and Composition of Committees"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/911096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=911096"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/911096\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=911096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=911096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=911096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}